Logo image of LESL

LESLIE'S INC (LESL) Stock Fundamental Analysis

NASDAQ:LESL - Nasdaq - US5270641096 - Common Stock - Currency: USD

0.6001  -0.03 (-5.05%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to LESL. LESL was compared to 121 industry peers in the Specialty Retail industry. LESL has a bad profitability rating. Also its financial health evaluation is rather negative. LESL has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

LESL had negative earnings in the past year.
LESL had a positive operating cash flow in the past year.
LESL had positive earnings in 4 of the past 5 years.
Each year in the past 5 years LESL had a positive operating cash flow.
LESL Yearly Net Income VS EBIT VS OCF VS FCFLESL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

1.2 Ratios

LESL's Return On Assets of -2.94% is on the low side compared to the rest of the industry. LESL is outperformed by 66.94% of its industry peers.
The Return On Invested Capital of LESL (6.06%) is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for LESL is in line with the industry average of 13.08%.
The 3 year average ROIC (12.93%) for LESL is well above the current ROIC(6.06%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -2.94%
ROE N/A
ROIC 6.06%
ROA(3y)4.91%
ROA(5y)6.95%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)12.93%
ROIC(5y)16.83%
LESL Yearly ROA, ROE, ROICLESL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

1.3 Margins

Looking at the Operating Margin, with a value of 4.75%, LESL is in the better half of the industry, outperforming 66.12% of the companies in the same industry.
LESL's Operating Margin has declined in the last couple of years.
The Gross Margin of LESL (35.61%) is comparable to the rest of the industry.
LESL's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.75%
PM (TTM) N/A
GM 35.61%
OM growth 3Y-32.03%
OM growth 5Y-17.56%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.83%
GM growth 5Y-2.61%
LESL Yearly Profit, Operating, Gross MarginsLESL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so LESL is still creating some value.
LESL has more shares outstanding than it did 1 year ago.
The number of shares outstanding for LESL has been reduced compared to 5 years ago.
LESL has a better debt/assets ratio than last year.
LESL Yearly Shares OutstandingLESL Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
LESL Yearly Total Debt VS Total AssetsLESL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

LESL has an Altman-Z score of 1.36. This is a bad value and indicates that LESL is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.36, LESL is not doing good in the industry: 70.25% of the companies in the same industry are doing better.
The Debt to FCF ratio of LESL is 23.90, which is on the high side as it means it would take LESL, 23.90 years of fcf income to pay off all of its debts.
LESL has a Debt to FCF ratio of 23.90. This is comparable to the rest of the industry: LESL outperforms 43.80% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 23.9
Altman-Z 1.36
ROIC/WACC0.83
WACC7.3%
LESL Yearly LT Debt VS Equity VS FCFLESL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

2.3 Liquidity

LESL has a Current Ratio of 1.76. This is a normal value and indicates that LESL is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.76, LESL is in the better half of the industry, outperforming 73.55% of the companies in the same industry.
LESL has a Quick Ratio of 1.76. This is a bad value and indicates that LESL is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.36, LESL is doing worse than 68.59% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.76
Quick Ratio 0.36
LESL Yearly Current Assets VS Current LiabilitesLESL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

3

3. Growth

3.1 Past

LESL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -114.29%.
The Revenue has decreased by -6.90% in the past year.
Measured over the past years, LESL shows a small growth in Revenue. The Revenue has been growing by 7.46% on average per year.
EPS 1Y (TTM)-114.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-10%
Revenue 1Y (TTM)-6.9%
Revenue growth 3Y-0.32%
Revenue growth 5Y7.46%
Sales Q2Q%0.73%

3.2 Future

Based on estimates for the next years, LESL will show a very strong growth in Earnings Per Share. The EPS will grow by 172.15% on average per year.
The Revenue is expected to grow by 2.62% on average over the next years.
EPS Next Y439.35%
EPS Next 2Y298.51%
EPS Next 3Y172.15%
EPS Next 5YN/A
Revenue Next Year0.22%
Revenue Next 2Y1.56%
Revenue Next 3Y2.62%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
LESL Yearly Revenue VS EstimatesLESL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
LESL Yearly EPS VS EstimatesLESL Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 0.4 0.6 0.8

6

4. Valuation

4.1 Price/Earnings Ratio

LESL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 4.32, the valuation of LESL can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of LESL indicates a rather cheap valuation: LESL is cheaper than 98.35% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.38. LESL is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 4.32
LESL Price Earnings VS Forward Price EarningsLESL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

LESL's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of LESL indicates a rather cheap valuation: LESL is cheaper than 96.69% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 3.36
EV/EBITDA 9.32
LESL Per share dataLESL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as LESL's earnings are expected to grow with 172.15% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y298.51%
EPS Next 3Y172.15%

0

5. Dividend

5.1 Amount

LESL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

LESLIE'S INC

NASDAQ:LESL (4/30/2025, 3:57:03 PM)

0.6001

-0.03 (-5.05%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)02-06 2025-02-06/amc
Earnings (Next)04-30 2025-04-30/amc
Inst Owners107.12%
Inst Owner Change0.6%
Ins Owners0.6%
Ins Owner Change0.13%
Market Cap111.16M
Analysts52.94
Price Target2.33 (288.27%)
Short Float %10.91%
Short Ratio3.13
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-42.57%
Min EPS beat(2)-82.56%
Max EPS beat(2)-2.59%
EPS beat(4)2
Avg EPS beat(4)-18.77%
Min EPS beat(4)-82.56%
Max EPS beat(4)6%
EPS beat(8)3
Avg EPS beat(8)-16%
EPS beat(12)5
Avg EPS beat(12)-6.8%
EPS beat(16)9
Avg EPS beat(16)1.44%
Revenue beat(2)0
Avg Revenue beat(2)-2.32%
Min Revenue beat(2)-3.74%
Max Revenue beat(2)-0.91%
Revenue beat(4)0
Avg Revenue beat(4)-3.65%
Min Revenue beat(4)-7.94%
Max Revenue beat(4)-0.91%
Revenue beat(8)2
Avg Revenue beat(8)-2.85%
Revenue beat(12)4
Avg Revenue beat(12)-1.25%
Revenue beat(16)8
Avg Revenue beat(16)1.6%
PT rev (1m)-9.33%
PT rev (3m)-29.8%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-45.6%
EPS NY rev (1m)0%
EPS NY rev (3m)-72.31%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.93%
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)-1.94%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 4.32
P/S 0.08
P/FCF 3.36
P/OCF 1.5
P/B N/A
P/tB N/A
EV/EBITDA 9.32
EPS(TTM)-0.03
EYN/A
EPS(NY)0.14
Fwd EY23.13%
FCF(TTM)0.18
FCFY29.76%
OCF(TTM)0.4
OCFY66.81%
SpS7.19
BVpS-1.19
TBVpS-2.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.94%
ROE N/A
ROCE 8.18%
ROIC 6.06%
ROICexc 6.15%
ROICexgc 8.56%
OM 4.75%
PM (TTM) N/A
GM 35.61%
FCFM 2.48%
ROA(3y)4.91%
ROA(5y)6.95%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)12.93%
ROIC(5y)16.83%
ROICexc(3y)14.82%
ROICexc(5y)24.05%
ROICexgc(3y)21.72%
ROICexgc(5y)36.28%
ROCE(3y)17.45%
ROCE(5y)22.71%
ROICexcg growth 3Y-44.76%
ROICexcg growth 5Y-34.55%
ROICexc growth 3Y-44.16%
ROICexc growth 5Y-29.4%
OM growth 3Y-32.03%
OM growth 5Y-17.56%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.83%
GM growth 5Y-2.61%
F-Score2
Asset Turnover1.38
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 23.9
Debt/EBITDA 8.22
Cap/Depr 124.85%
Cap/Sales 3.09%
Interest Coverage 1.01
Cash Conversion 77.21%
Profit Quality N/A
Current Ratio 1.76
Quick Ratio 0.36
Altman-Z 1.36
F-Score2
WACC7.3%
ROIC/WACC0.83
Cap/Depr(3y)119.65%
Cap/Depr(5y)107.77%
Cap/Sales(3y)2.75%
Cap/Sales(5y)2.45%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-114.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-10%
EPS Next Y439.35%
EPS Next 2Y298.51%
EPS Next 3Y172.15%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.9%
Revenue growth 3Y-0.32%
Revenue growth 5Y7.46%
Sales Q2Q%0.73%
Revenue Next Year0.22%
Revenue Next 2Y1.56%
Revenue Next 3Y2.62%
Revenue Next 5YN/A
EBIT growth 1Y-36.91%
EBIT growth 3Y-32.25%
EBIT growth 5Y-11.41%
EBIT Next Year29.26%
EBIT Next 3Y17.23%
EBIT Next 5YN/A
FCF growth 1Y236.69%
FCF growth 3Y-24.58%
FCF growth 5Y14.65%
OCF growth 1Y852.08%
OCF growth 3Y-14.06%
OCF growth 5Y13.21%